Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
GOSS | Gossamer Bio, Inc. | President & CEO, Director | $3.72M | +$224K | +6.39% | Jun 21, 2024 |
KURA | Kura Oncology, Inc. | Director | Jun 5, 2024 | |||
MRTX | Mirati Therapeutics, Inc. | Director | Jan 23, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|